U.S. stock index futures traded slightly higher on Friday, though they pared some gains just ahead of the release of July retail sales data.
- Among the indices, the Dow Jones Industrial Average (US30) stands out, supported by renewed buying interest in shares of key U.S. health insurer UnitedHealth (UNH.US). Berkshire Hathaway revealed a stake in the company, boosting its stock price. Similar gains are seen in homebuilding names Lennar and DR Horton.
- Investors are also watching Intel, which is breaking above key technical resistance levels on news that the U.S. government may take a stake in the chipmaker.
- U.S. President Donald Trump and Russian President Vladimir Putin are set to discuss a possible ceasefire in Ukraine (7 PM GMT)
Traders await key U.S. macroeconomic releases:
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app-
12:30 PM GMT – July retail sales
-
1:15 PM GMT – Industrial production
-
2 PM GMT – University of Michigan consumer sentiment and inflation expectations (August prelim)
US30 (Daily Interval)
Source: xStation5
Company News
-
UnitedHealth (UNH.US) – Shares jumped 11% after Warren Buffett’s Berkshire Hathaway disclosed a new investment in the unpopular health insurer. Investors see this as a potential “value” opportunity despite regulatory uncertainty and possible penalties related to Medicare programs.
-
Intel (INTC.US) – Pre-market gains of nearly 4%, extending earlier advances, after Bloomberg reported the Trump administration is considering taking a stake in the chipmaker. The market views this move as strategically securing Intel’s position as a key domestic producer with reliable supply chains.
-
Applied Materials (AMAT.US) – Shares plunged nearly 15% after the semiconductor equipment maker issued weak fourth-quarter guidance due to sluggish Chinese demand. The report heightened concerns over tariff-related risks and underscored that heavy exposure to China is overshadowing growth in the U.S. business.
-
DR Horton (DHI.US) & Lennar (LEN.US) – Both up close to 4% after Berkshire Hathaway increased its exposure to the U.S. homebuilding sector, revealing a new stake in DR Horton and a significantly larger position in Lennar.
-
Target (TGT.US) – Shares fell nearly 2% after Bank of America downgraded the retailer from “neutral” to “underperform,” citing a “deteriorating” long-term outlook and mounting competitive pressure from major rivals.
-
SanDisk (SNDK.US) – Down nearly 10% despite strong quarterly results, as the flash memory maker failed to meet investors’ unofficial expectations, triggering profit-taking.
-
Tapestry (TPR.US) – Up 2% after Wells Fargo raised its price target while maintaining its “overweight” rating, saying the recent sell-off was overdone.
-
Twilio (TWLO.US) – Gained over 4% as the cloud communications company is set to join the S&P MidCap 400 following UnitedHealth’s acquisition of Amedisys, which could prompt increased institutional buying.
UnitedHealth in Focus
Following massive recent declines, UnitedHealth’s share price is now nearly 50% below its all-time high and still around 25–30% below its 200-day EMA (red line) — a situation last seen during the COVID-19 panic. Buffett’s involvement may signal to investors that UNH is now attractively valued, prompting Wall Street to reassess the company’s long-term fundamentals.
Intel Breakout
Intel shares moved above the 200-day EMA yesterday, reversing a downward trend. Today’s pre-market gains open the way toward local highs.
Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
